Serum phosphate is associated with increased risk of bone fragility fractures in hemodialysis patients.
Pedro Barrera-BaenaMinerva Rodríguez-GarcíaEnrique Rodríguez-RubioLucía González-LlorenteAlberto Ortiz ArduanCarmine ZoccaliFrancesco LocatelliJürgen FloegeMartine Cohen-SolalManuel Aníbal FerreiraMarkus KettelerGerard Michel LondonJose Luis Gorriz TeruelJosé Emilio Sánchez-ÁlvarezMiguel Ángel Hevia-SuárezJesús María Fernández-GómezBeatriz Martín-CarroCarlos Gómez-AlonsoCristina Alonso-MontesJorge Benito Cannata-AndiaJosé Luis Fernández-Martínnull nullPublished in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2023)
Hyperphosphatemia was independently and consistently associated with an increased bone fracture risk, suggesting serum phosphate could be a novel risk factor for bone fractures in hemodialysis patients.